The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
RCEL | -61.31% | -82.94% | -29.78% | -84% |
S&P | +14.5% | +93.32% | +14.09% | +377% |
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $18.42M | 21.2% |
Gross Profit | $14.95M | 14.3% |
Gross Margin | 81.17% | -4.9% |
Market Cap | $131.42M | -33.2% |
Market Cap / Employee | $0.51M | 0.0% |
Employees | 260 | 25.6% |
Net Income | -$9.92M | 35.6% |
EBITDA | -$10.60M | 31.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $12.22M | -30.0% |
Accounts Receivable | $11.34M | 30.1% |
Inventory | 7.5 | 12.3% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $2.37M | -94.6% |
Short Term Debt | $42.22M | 5048.3% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | -70.67% | -13.4% |
Return On Invested Capital | -65.05% | -29.8% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | -$10.98M | 29.1% |
Operating Free Cash Flow | -$10.45M | 18.5% |
Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
---|---|---|---|---|---|
Price to Book | 11.63 | 27.45 | 47.68 | -30.59 | -587.81% |
Price to Sales | 4.64 | 5.21 | 2.98 | 1.86 | -50.57% |
Price to Tangible Book Value | 11.90 | 28.84 | -200.30 | -13.96 | -318.88% |
Enterprise Value to EBITDA | -20.73 | -35.98 | -20.52 | -15.89 | 25.46% |
Return on Equity | -152.4% | -231.0% | -407.5% | -935.7% | 769.12% |
Total Debt | $45.63M | $45.99M | $44.07M | $44.59M | -1.11% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.